MONTROUGE, France

Pierre-louis Herve

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pierre-Louis Herve: Innovator in Epicutaneous Vaccination

Introduction

Pierre-Louis Herve is a notable inventor based in Montrouge, France. He has made significant contributions to the field of vaccination through his innovative approaches to epicutaneous administration methods. His work focuses on improving the effectiveness of vaccinations, which is crucial for public health.

Latest Patents

Pierre-Louis Herve holds a patent for an "Optimized Epicutaneous Vaccination." This invention relates to improved methods for the epicutaneous administration of vaccines. Specifically, it discloses the use of an antigen for epicutaneous immunization, where the antigen is applied using a skin patch device in combination with an epidermal skin treatment. This innovative approach aims to enhance the immunization process and improve patient outcomes.

Career Highlights

Throughout his career, Pierre-Louis Herve has worked with several prominent companies in the biotechnology sector. Notably, he has been associated with DBV Technologies and Bionet-Asia, Co. Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas in vaccination technology.

Collaborations

Pierre-Louis Herve has collaborated with various professionals in his field. Some of his notable coworkers include Hong Thai Pham and Nathalie Donne. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

In summary, Pierre-Louis Herve is a distinguished inventor whose work in epicutaneous vaccination represents a significant advancement in immunization methods. His innovative patent and collaborations highlight his commitment to improving public health through effective vaccination strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…